Polysaccharides from Glycyrrhiza are known to have several bioactive
effects. Current studies on polysaccharides mainly focused on the
biological activity of mixed components or large molecular weight
polysaccharides. However, the structure-activity relationship between
polysaccharides and immune regulation is still unclear. In this work, a
low molecular weight GP1 (6.5 kDa) mainly composed of glucose was
purified. Its backbone was determined as →4)-α-D-Glcp-(1→,
→6)-α-D-Glcp-(1→ (9.3%), →4,6)-α-D-Glcp-(1→ and α-D-Glcp-(1→ residues.
This structure gives GP1 the good antioxidant ability (91.85%) and
phagocytic activity (129.15%) of RAW264.7 cell. Through in-vitro
simulation, it was found that GP1 could be degraded by intestinal flora,
increase the production of SCFAs by 83.44%, and promote the
proliferation of beneficial bacteria. Further studies showed that GP1
effectively increased body weight, immune organ index, and intestinal
barrier function of immunosuppressed mice. And GP1 also promoted the
proliferation of goblet cells, CD4+ and CD8+ T lymphocytes by 31.40%,
20.61% and 50.15%, respectively. Meanwhile, GP1 also activated the
expression ofTLR2, TLR4 and TLR6 gene in the TLR signaling pathway on
the immune cell surface, thereby increasing the release of cytokines.
These results indicated that the immunomodulatory of GP1 was closely
related to intestinal flora, immune cell and TLR genes up-regulation.